In conclusion, PTPRH affects glycolysis in NSCLC cells via the PI3K/AKT/mTOR signaling pathway and ultimately promotes tumor progression in NSCLC, which could be regulated by LY294002 and 740Y-P. Here, MTOR is linked to neoplasm.